Back to BlackRock, Inc. BlackRock, Inc.

ABOSABOS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ACUMEN PHARMACEUTICALS INC

BlackRock, Inc. holds 2.5M shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $6.6M as of 2026-Q2. The position was increased (+1296.4% shares). ABOS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$6.6M

Current Shares

2.5M

Total Value Change

+$866,412

Total Shares Change

+158,585

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+1296.4%
$6.6M0.0%$2.67
44
2026-Q1
Increased
178,326
+5.2%
$420,8490.0%$2.36
17
2025-Q4
Decreased
169,505
-3.0%
$357,6550.0%$2.11
0
2025-Q3
Decreased
174,690
-40.2%
$298,7190.0%$1.71
0
2025-Q2
Decreased
291,957
-87.5%
$338,6710.0%$1.16
0
2025-Q1
Decreased
2.3M
-1.7%
$2.6M0.0%$1.10
0
2024-Q4
Increased
2.4M
+1.7%
$4.1M0.0%$1.72
27
2024-Q3
First report
2.3M
-
$5.8M0.0%$2.48
0

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used